Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients
Sponsor: Children's Mercy Hospital Kansas City
Summary
The study is an interventional, non-randomized assessment of safety and efficacy of live Measles, Mumps and Rubella (MMR) vaccine in subjects aged 12-months to 17 years who have undergone heart transplantation. Subjects who provide permission/assent will receive the commercial MMR vaccine according to product indication and labeling.
Key Details
Gender
All
Age Range
1 Year - 17 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-09-11
Completion Date
2027-09-11
Last Updated
2025-09-26
Healthy Volunteers
No
Conditions
Interventions
Commercial measles, mumps, and rubella (MMR) vaccine
Participants will receive the commercial MMR vaccine if they are deemed eligible for the study.
Locations (1)
Children's Mercy Hospital
Kansas City, Missouri, United States